Atorvastatin Calcium Tablet
Product Images NDC 70710-1775

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70710-1775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 01)

Chemical structure of atorvastatin calcium showing its molecular arrangement including calcium ions and water molecules. The diagram illustrates the detailed atomic connectivity of the active ingredient atorvastatin calcium in its hydrated form.*

FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 02)

A line graph comparing cumulative incidence (%) over time (years) between atorvastatin and placebo groups. The solid line represents atorvastatin, showing lower cumulative incidence than the dashed placebo line. The graph includes a hazard ratio (HR=0.64) with confidence interval and a p-value indicating statistical significance.*

FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 03)

A line chart comparing cumulative hazard percentages over time between atorvastatin and placebo groups. The x-axis represents time to first primary endpoint over four years of follow-up in years, and the y-axis shows cumulative hazard percentage. The plot includes a hazard ratio (HR) with confidence interval and p-value.*

FDA Label Image

Image (393b5ee9 C102 40ee 9d07 B676ece72abd 04)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over time (years) for atorvastatin 10 mg versus atorvastatin 80 mg. The x-axis represents time to the event in years, and the y-axis shows the percentage of subjects experiencing the event. Two lines plot the data: a dashed line for atorvastatin 10 mg and a solid line for atorvastatin 80 mg, with a hazard ratio and statistical significance indicated.*

FDA Label Image

Sl-10mg-90c (393b5ee9 C102 40ee 9d07 B676ece72abd 05)

Label for Atorvastatin Calcium Tablets USP 10 mg by Zydus Pharmaceuticals USA Inc. The label shows the tablet strength as 10 mg and indicates a package size of 90 tablets. It includes storage instructions, caution that the package is child-resistant, and manufacturer and distributor information for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals USA Inc.*

FDA Label Image

20mg-90c (393b5ee9 C102 40ee 9d07 B676ece72abd 06)

Atorvastatin Calcium Tablets USP 20 mg oral tablet label by Zydus Pharmaceuticals USA Inc. The package contains 90 tablets, prescription use only. The label includes storage information, manufacturer Zydus Lifesciences Ltd. in India, and distributor details in the USA. The label is marked with NDC 70710-1775-9 and a barcode.*

FDA Label Image

40mg-90c (393b5ee9 C102 40ee 9d07 B676ece72abd 07)

Label for Atorvastatin Calcium Tablets, USP 40 mg by Zydus Pharmaceuticals USA Inc. The label indicates a package of 90 oral tablets, prescription only. It includes storage instructions, child-resistant packaging information, and details that each film-coated tablet contains atorvastatin calcium equivalent to 40 mg atorvastatin.*

FDA Label Image

80mg-90c (393b5ee9 C102 40ee 9d07 B676ece72abd 08)

Atorvastatin Calcium Tablets, USP 80 mg oral tablets packaging label from Zydus Pharmaceuticals USA Inc., displaying a bottle with 90 tablets. Label includes dosage strength, child-resistant packaging notice, storage instructions, manufacturer (Zydus Lifesciences Ltd.), and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.